As expected, our data demonstrated that Au-si-CYP2S1 selectively inhibited BRAFV600E-mutated thyroid cancer cells, while almost did not affect the growth of BRAFV600E wild-type ones. The gene discussed is CYP2S1; the disease is thyroid cancer.